Skip to main content
. Author manuscript; available in PMC: 2021 Mar 22.
Published in final edited form as: Cancer. 2020 Feb 25;126(10):2174–2182. doi: 10.1002/cncr.32773

TABLE 2.

Post Hoc Pairwise Comparisons (Tukey HSD) of Scores at Each Time Point Between Recipients of Autologous and Allogeneic BMT and Healthy Controlsa

Autologous BMT Versus Healthy Control
Allogeneic BMT Versus Healthy Control
Time Point 0 1 2 3 4 0 1 2 3 4
NIS subscale
 Critical Items 9.34 8.47 7.51 7.01 5.60 8.26 7.62 6.23 9.87 10.83
  95% CI 12.5/6.1 12.1/4.8 11.3/3.8 10.9/3.1 9.7/1.5 11.4/5.1 11.0/4.3 9.6/2.9 13.3/6.5 14.6/7.0
  P <.001 <.001 <.001 <.001 .004 <.001 <.001 <.001 <.001 <.001
 Cognitive Efficiency 10.2 10.1 7.36 6.20 7.63 9.06 8.33 8.17 8.79 10.08
  95% CI 13.9/6.5 14.6/5.1 11.6/3.2 10.9/1.5 12.3/2.9 12.8/5.4 12.4/4.3 11.9/4.4 12.9/4.7 14.5/5.7
  P <.001 <.001 <.001 .006 .001 <.001 <.001 <.001 <.001 <.001
 Attention 6.03 6.82 5.91 4.47 5.87 5.46 3.14 4.85 6.47 7.51
  95% CI 10.1/2.0 11.5/2.1 10.6/1.2 9.6/−0.60 11.2/0.57 9.5/1.5 7.5/−1.2 9.0/0.67 10.9/2.0 12.4/2.6
  P .002 .002 .009 .097 .026 .004 .20 .018 .002 .001
 Memory 4.54 6.45 6.06 3.86 6.05 5.05 2.79 4.51 6.56 8.71
  95% CI 8.4/0.71 10.7/2.1 10.3/1.8 8.8/−1.0 10.9/1.2 8.8/1.3 6.7/−1.1 8.3/0.71 10.9/2.3 13.2/4.2
  P .015 .001 .003 .15 .01 .005 .22 .015 .001 <.001
 Frustration Tolerance 7.10 5.95 3.83 4.10 3.90 6.65 4.52 3.68 7.95 7.09
  95% CI 11.1/3.2 9.8/2.1 7.7/−0.04 8.5/−0.28 8.3/−0.48 10.2/3.1 8.1/0.95 7.2/0.22 11.8/4.1 11.2/3.0
  P <.001 .001 .05 .072 .127 <.001 .009 .034 <.001 <.001
 Learning-Verbal 6.36 7.9 7.23 6.54 4.66 6.62 4.49 6.04 7.40 8.65
  95% CI 9.9/2.8 12.1/3.6 11.2/3.2 11.3/1.8 8.1/0.01 10.2/3.1 8.4/0.60 9.6/2.5 11.6/3.2 13.0/4.3
  P <.001 <.001 <.001 .004 .049 <.001 .019 <.001 <.001 <.001
 Academic Skills 6.54 4.79 4.70 3.46 3.62 5.70 3.08 4.42 5.95 7.23
  95% CI 10.5/2.6 9.2/0.41 9.0/0.40 8.4/−1.5 8.5/−1.2 9.6/1.8 7.1/−0.95 8.3/0.57 10.3/1.6 11.7/2.7
  P <.001 .028 .028 .225 .183 .002 .17 .02 .004 .001
 GMI 9.51 9.09 7.73 6.61 7.36 8.60 6.43 7.54 10.26 11.72
  95% CI 13.5/5.5 13.8/4.4 12.4/3.1 11.6/1.6 12.4/2.3 12.5/4.7 10.7/2.1 11.7/3.4 14.7/5.8 16.4/7.0
  P <.001 <.001 <.001 .006 .002 <.001 .001 <.001 <.001 <.001

Abbreviations: 0, before blood or bone marrow transplantation; 1, 6 months after blood or bone marrow transplantation; 2, 1 year after blood or bone marrow transplantation; 3, 2 years after blood or bone marrow transplantation; 4, 3 years after blood or bone marrow transplantation; BMT, blood or bone marrow transplantation; GMI, Global Measure of Impairment; HSD, honestly significant difference; NIS, Neuropsychological Impairment Scale.

a

Data are the estimate of the mean score difference. 95% CIs indicate upper bound/lower bound values. Bolded values indicate a P ≤ .003 significance level, adjusted for multiple comparisons. A positive value indicates greater self-endorsed cognitive problems on the NIS subscale in BMT recipients when compared with healthy controls.